142 related articles for article (PubMed ID: 17711162)
1. [Current treatment in high risk and locally advanced prostate cancer].
Esquena Fernández S; Maroto Rey P; Sancho Pardo G; Palou Redorta J; Villavicencio Mavrich H
Actas Urol Esp; 2007 May; 31(5):445-51. PubMed ID: 17711162
[TBL] [Abstract][Full Text] [Related]
2. Treatment of locally advanced prostate cancer: is chemotherapy the next step?
Oh WK; Kantoff PW
J Clin Oncol; 1999 Nov; 17(11):3664-75. PubMed ID: 10550165
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
Milecki P; Kwias Z; Martenka DJ
Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
[TBL] [Abstract][Full Text] [Related]
4. The Role of Radical Prostatectomy and Radiotherapy in Treatment of Locally Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
Fahmy O; Khairul-Asri MG; Hadi SHSM; Gakis G; Stenzl A
Urol Int; 2017; 99(3):249-256. PubMed ID: 28675891
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis.
Berglund RK; Jones JS; Ulchaker JC; Fergany A; Gill I; Kaouk J; Klein EA
Urology; 2006 Jun; 67(6):1253-6. PubMed ID: 16678888
[TBL] [Abstract][Full Text] [Related]
6. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
7. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy for clinical T4 prostate cancer.
Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
10. Survival and secondary interventions following treatment for locally-advanced prostate cancer.
Sussman R; Carvalho FLF; Harbin A; Zheng C; Lynch JH; Stamatakis L; Hwang J; Williams SB; Hu JC; Kowalczyk KJ
Can J Urol; 2018 Oct; 25(5):9516-9524. PubMed ID: 30281010
[TBL] [Abstract][Full Text] [Related]
11. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
Nair B; Wilt T; MacDonald R; Rutks I
Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
[TBL] [Abstract][Full Text] [Related]
12. [Endocrine therapy for localized or locally advanced prostate cancer].
Fontaine E; Ruffion A; Staerman F
Prog Urol; 2004 Jun; 14(3):433-6. PubMed ID: 15373195
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer: a preliminary report.
Kalapurakal JA; Pierce M; Chen A; Sathiaseelan V
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):654-64. PubMed ID: 14529769
[TBL] [Abstract][Full Text] [Related]
14. Locally advanced prostate cancer: effective treatments, but many adverse effects.
Prescrire Int; 2013 Jan; 22(134):18-20, 22-3. PubMed ID: 23367679
[TBL] [Abstract][Full Text] [Related]
15. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; Van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Eur Urol; 2011 Apr; 59(4):572-83. PubMed ID: 21315502
[TBL] [Abstract][Full Text] [Related]
16. [Radical prostatectomy in locally advanced prostate cancer].
Mandel P; Tilki D; Graefen M
Urologe A; 2017 Nov; 56(11):1394-1401. PubMed ID: 28983643
[TBL] [Abstract][Full Text] [Related]
17. Locally advanced prostate cancer: current controversies and optimisation opportunities.
Sridharan S; Dal Pra A; Catton C; Bristow RG; Warde P
Clin Oncol (R Coll Radiol); 2013 Aug; 25(8):499-505. PubMed ID: 23680106
[TBL] [Abstract][Full Text] [Related]
18. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
[TBL] [Abstract][Full Text] [Related]
19. 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.
Mitchell CR; Boorjian SA; Umbreit EC; Rangel LJ; Carlson RE; Karnes RJ
BJU Int; 2012 Dec; 110(11):1709-13. PubMed ID: 22934913
[TBL] [Abstract][Full Text] [Related]
20. Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7.
Fosså SD; Wiklund F; Klepp O; Angelsen A; Solberg A; Damber JE; Hoyer M; Widmark A;
Eur Urol; 2016 Oct; 70(4):684-691. PubMed ID: 27025586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
